The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer

por Döppler, Heike, Panayiotou, Richard, Reid, Elizabeth M., Maimo, Willibroad, Bastea, Ligia, Storz, Peter
Publicado 2016

Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death

por Bastea, Ligia I., Hollant, Laeticia M. A., Döppler, Heike R., Reid, Elizabeth M., Storz, Peter
Publicado 2019